Analyst firms · Maxim Group · ZVRA

Maxim Group ZVRA price target and rating history

Zevra Therapeutics Inc. (ZVRA) · Health Care

Maxim Group rates Zevra Therapeutics Inc. (ZVRA) Buy with a $25 price target, as of its latest action on Sep 24, 2024. It has published 3 rating actions on ZVRA since March 2023, including 0 upgrades and 0 downgrades.

Current rating
Buy
Price target
$25
Median target, all firms
Too few
Actions on ZVRA
3

Maxim Group price target on ZVRA

$25$19$12202420252026
Maxim Group price target on ZVRA, each point a stated target, March 2023 to September 2024.

Every Maxim Group rating on ZVRA

Questions about Maxim Group and ZVRA

What is Maxim Group's price target for ZVRA?
Maxim Group's latest stated price target for Zevra Therapeutics Inc. (ZVRA) is $25, from its action on Sep 24, 2024.
What is Maxim Group's rating on ZVRA?
Maxim Group rates ZVRA Buy, a bullish rating, as of Sep 24, 2024.
When did Maxim Group last change its view on ZVRA?
On Sep 24, 2024, Maxim Group raises its price target to $25 from $18, keeps Buy.

All Maxim Group ratingsZVRA news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.